Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53

被引:118
作者
Nozawa, H
Oda, E
Nakao, K
Ishihara, M
Ueda, S
Yokochi, T
Ogasawara, K
Nakatsuru, Y
Shimizu, S
Ohira, Y
Hioki, K
Aizawa, S
Ishikawa, T
Katsuki, M
Muto, T
Taniguchi, T
Tanaka, N [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo 1130033, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan
[4] Univ Tokyo, Fac Med, Tokyo 1130033, Japan
[5] Univ Tokyo, Dept Dna Biol & Embryo Engn, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan
[6] Cent Inst Expt Anim, Miyamae Ku, Kawasaki, Kanagawa 2160001, Japan
[7] Kumamoto Univ, Fac Med, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan
关键词
IRF-1; c-Ha-ras; p53; tumor susceptibility gene; mutation frequency;
D O I
10.1101/gad.13.10.1240
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The transcription factor IRE-I has been implicated in tumor suppression: IRF-1 suppresses cell transformation and mediates apoptosis in vitro. Here we show that the loss of IRF-1 alleles per se has no effect on spontaneous turner development in the mouse but dramatically exacerbates previous tumor predispositions caused by the c-Ha-ras transgene or by nullizygosity for p53. Grossly altered tumor spectrum, as compared to p53-null mice, was also observed in mice lacking both IRE-I and p53, and cells from these mice show significantly higher mutation rate. Our results suggest that IRF-1 is a new member of the tumor susceptibility genes.
引用
收藏
页码:1240 / 1245
页数:6
相关论文
共 41 条
  • [11] Hawkins DS, 1996, CANCER RES, V56, P892
  • [12] EFFECTS OF AN RB MUTATION IN THE MOUSE
    JACKS, T
    FAZELI, A
    SCHMITT, EM
    BRONSON, RT
    GOODELL, MA
    WEINBERG, RA
    [J]. NATURE, 1992, 359 (6393) : 295 - 300
  • [13] Lessons from the p53 mutant mouse
    Jacks, T
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (06) : 319 - 327
  • [14] REQUIREMENT FOR TRANSCRIPTION FACTOR IRF-1 IN NO SYNTHASE INDUCTION IN MACROPHAGES
    KAMIJO, R
    HARADA, H
    MATSUYAMA, T
    BOSLAND, M
    GERECITANO, J
    SHAPIRO, D
    LE, J
    KOH, SI
    KIMURA, T
    GREEN, SJ
    MAK, TW
    TANIGUCHI, T
    VILCEK, J
    [J]. SCIENCE, 1994, 263 (5153) : 1612 - 1615
  • [15] INVOLVEMENT OF THE IRF-1 TRANSCRIPTION FACTOR IN ANTIVIRAL RESPONSES TO INTERFERONS
    KIMURA, T
    NAKAYAMA, K
    PENNINGER, J
    KITAGAWA, M
    HARADA, H
    MATSUYAMA, T
    TANAKA, N
    KAMIJO, R
    VILCEK, J
    MAK, TW
    TANIGUCHI, T
    [J]. SCIENCE, 1994, 264 (5167) : 1921 - 1924
  • [16] Landscaping the cancer terrain
    Kinzler, KW
    Vogelstein, B
    [J]. SCIENCE, 1998, 280 (5366) : 1036 - 1037
  • [17] Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo
    Lohoff, M
    Ferrick, D
    Mittrucker, HW
    Duncan, GS
    Bischof, S
    Rollinghoff, M
    Mak, TW
    [J]. IMMUNITY, 1997, 6 (06) : 681 - 689
  • [18] MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8
  • [19] REGULATED EXPRESSION OF A GENE ENCODING A NUCLEAR FACTOR, IRF-1, THAT SPECIFICALLY BINDS TO IFN-BETA-GENE REGULATORY ELEMENTS
    MIYAMOTO, M
    FUJITA, T
    KIMURA, Y
    MARUYAMA, M
    HARADA, H
    SUDO, Y
    MIYATA, T
    TANIGUCHI, T
    [J]. CELL, 1988, 54 (06) : 903 - 913
  • [20] Nagy A., 1993, Gene targeting: a practical approach., P147